The growth of the Sabin strain of type 3 poliovirus is reduced at high temperatures compared to that of its virulent precursor strain Leon. Recombinant viruses have been generated from infectious cDNA clones and demonstrate that the temperaturesensitive (ts) phenotype is mainly attributable to a difference in residue 91 of the virion protein VP3. Examination of non-ts mutants derived in vitro or in rive reveals the existence of second site mutations some of which are clearly able to suppress the ts phenotype. The location of residue 91 of VP3, and of a number of candidate suppressor mutations, in the atomic structure of the virion suggests that the ts phenotype may result in destabilization of the particle and that the suppressors may function by stabilizing specific interfaces. It is not yet clear whether the ts phenotype is expressed at the level of the particle or in the form of defects in assembly or uncoating of the virion, or all three.
INTRODUCTION
Polioviruses are the causative agents of poliomyelitis and occur in three distinct serotypes designated 1, 2 and 3. In developed countries poliomyelitis has been effectively controlled by vaccination with either the inactivated virus vaccine described by Sulk (Salk et al., 1978) or the live non-paralytic attenuated strains described by Sabin (Sabin & Boulger, 1973) . In recent years the molecular basis of the attenuated phenotype of the Sabin type 1 and type 3 strains has been examined by the use of sequencing and recombinant DNA techniques. Although the type 1 strain appears to have acquired numerous attenuating mutations in the course of its derivation from the Mahoney strain (Nomoto et al., 1982; Omata et al., 1986) we have previously reported that the situation with the type 3 strain appears to be simpler, with two mutations accounting for the largest part of the attenuated phenotype compared to the precursor strain Leon (Cann et al., 1984; Evans et al., 1985; Westrop et al., 1986; G. D. Westrop et al., unpublished data) .
Polioviruses are picomaviruses in which the virion consists of 60 copies of each of four eapsid proteins (Hogle et al., 1985) surrounding a messenger-sense genomic RNA of about 7500 nucleotides. The RNA contains a single large open reading frame encoding the structural and non-structural proteins flanked by a 5' non-coding region of about 750 bases and a 3' non-coding region of about 70 bases. The attenuating mutations previously identified in the Sabin type 3 strain were at residue 472 in the 5' non-coding region of the genome, and at residue 2034, leading to a coding change in the structural protein VP3 at amino acid 91.
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The growth of the Sabin type 3 strain is known to be more sensitive to elevated temperatures than that of the precursor strain Leon. It was thus of interest to identify the basis of the temperature-sensitive (ts) phenotype by the same methods used to identify the attenuating mutations. One approach involved the construction of recombinant viruses between Leon and the Sabin type 3 strain Leon 12a~b by manipulation of genomic length cDNA clones, followed by recovery of infectious virus by transfection of susceptible cells (Racaniello & Baltimore, 1981) . A second approach involved the examination of strains isolated from cases of poliomyelitis associated with vaccination (WHO Report, 1981) where the strains were neurovirulent and their growth was insensitive to elevated temperatures. The results indicate that the attenuating mutation in the capsid protein VP3 is the major determinant of the ts phenotype in HEp-2c cells, and that its effect may be wholly or partially suppressed by second site mutations within the coat proteins. The findings are presented in the light of the published X-ray crystallographic structure of the virus (Hogle et al., 1985; J. M. Hogle et al., unpublished data) .
METHODS
Virus and cells. Virus and cells were grown as described elsewhere (Minor et al., 1986a) . Recombinant strains. The construction of the recombinants between Leon and the Sabin type 3 strains has been described elsewhere (Westrop et al., 1986; G. D. Westrop et al., unpublished data) . Briefly, complete cDNA clones of the two strains were prepared and segments were exchanged using convenient restriction sites. The resulting plasmids were transfected into HEp-2 cells at 35 °C to produce infectious virus.
Plaque assays. Plaque assays were performed on HEp-2c cell monolayers in six-well plates as described (Minor et al., 1986a) . After overlaying with 1 ~o agar in L 15 medium supplemented with 5 % foetal calf serum, plates were incubated in sealed plastic boxes submerged in water baths whose temperature was controlled to + 0.1 °C. Cell sheets were incubated for 3 to 4 days and plaques were picked with Pasteur pipettes before staining of the cells with naphthalene black.
RNA sequencing. The sequence of the genomic RNA of purified viruses was determined by the dideoxynucleotide chain termination method described by Evans et al. (1985) , using synthetic oligonucleotide primers.
RESULTS

Recombinant viruses
The constructs studied and the 10 base differences between the Leon and Sabin strains are shown in Table 1 . Viruses were subjected to plaque purification at 35 °C before study.
The ability of the viruses to replicate in HEp-2c cells was assessed by plaque formation at a range of temperatures from 35 to 40 °C. Each construct was examined several times and the results are summarized in Table 1 as the ratio of numbers of plaques formed at 35 °C to numbers formed at 40 °C. In general, significant reductions were only observed at 40 °C, under the conditions used.
It was found that the growth of Leon was not sensitive to elevated temperatures when the virus was obtained either from the cDNA clone or by conventional culture methods. Similarly the Sabin vaccine strain derived from either cDNA clones or conventional culture methods invariably failed to form plaques at 40 °C; a reduction in virus titre of at least 6 loglo units compared to that at 35 °C. The process of recovery from a cDNA clone did not therefore affect the plaquing characteristics of the parental viruses.
The growth of the recombinant viruses S5'/L, SVI/L, SP2/L and S3'/L was only slightly affected by incubation at 40 °C, the titres being reduced by 1-4, 0.5, 1-7 and 0-4 loglo respectively. The genomes of these viruses were like that of strain Leon except for limited portions of Sabin sequences. Thus S5'/L was Sabin-like in the 5' portion of the genome, SV 1/L in the region coding for the capsid protein VP1, SP2/L in the region coding for the non-structural protein P2-3b and S3'/L in the region to the 3' end of the genome.
A fifth recombinant, SV3/L, differed from Leon only at residue 91 of the capsid protein VP3. The titre of SV3/L was reduced by 3.4 logmo at 40 °C, and plaques picked at 40 °C proved to be significantly less temperature sensitive than the parent, showing a reduction in titre of only 1.0 logxo (data not shown). The frequency with which such temperature insensitive mutants arose from SV3/L was that expected of a single point mutation in an RNA genome (Minor et al., 
* Coding change in VP3 residue 91 from serine (Leon) to phenylalanine (Sabin) . t Coding change in VP1 residue 286 from lysine (Leon) to arginine (Sabin) . :~ Coding change in P2a residue 30 from threonine (Leon) to alanine (Sabin) . § S, Sabin type 3 nucleotide at the position indicated.
1986a). The single mutation conferring the most significant temperature sensitivity of growth of the Sabin type 3 vaccine strain relative to the precursor strain Leon was thus in VP3.
The phenomenon was investigated further by examining more complex constructs. Recombinant SLR1 included the Sabin-like portions of S5'/L and SV3/L in one virus, while SCC/L was Sabin-like at VP3, VP1 and P2-3b as well as at the silent mutation at base 871. Growth of both viruses was of similar temperature sensitivity to SV3/L, a reduction in titre of 3.9 log10 to 4-4 log10 being consistently observed at 40 °C compared to 35 °C (Table 1) . As for SV3/L, plaques picked at 40 °C were able to grow at 40 °C as effectively as at 35 °C. The ts phenotype of these viruses could thus be accounted for by the mutation in VP3 alone. In particular the addition of the mutations in SS'/L or in SP2/L had no effect, suggesting that the apparent slightly ts phenotype of these constructs was an artefact of the preparation of the viruses or their assay.
This conclusion was consistent with the properties of two further constructs. Virus $5'3'/L contained the Sabin 5' and 3' termini, and was Leon-like in VP3, VP 1 and P2-3b. Growth of this virus was insensitive to elevated temperatures, confirming that the genome 5' end did not render virus growth ts. Similarly SLR2 which was Sabin-like from VP1 to the 3' terminus was completely temperature resistant suggesting that the VP1 and P2-3b mutations had no effect on growth at elevated temperatures. It is possible that the slight effects observed with S5'/L and SP2/L reflect variation between experiments, heterogeneity in the virus stock examined despite plaque purification or undetected mutations in the genome introduced in the course of manipulation or transfection of the recombinant plasmids.
The only mutation consistently shown to render virus growth in HEp-2 cells significantly ts was thus the alteration in residue 91 of VP3.
Mutant viruses
The basis of the ts phenotype was studied further by examining mutant strains related to the Sabin strain. Four were derived by in vitro selection from the recombinant viruses discussed above, and 12 were from cases of poliomyelitis associated with vaccination (WHO Report, 1981) . The growth of two strains, 131 and P3/382/UK/1962, isolated from vaccine-associated cases was partially sensitive to high temperatures while that of the remainder was completely resistant. The genomic RNAs of all 16 strains were sequenced by the dideoxynucleotide primer extension method through the region coding for the structural proteins. The results are shown in Table 2 . Each of the four mutants selected from the recombinant viruses in vitro had a single base substitution leading to a predicted amino acid change. One, SCC/L 1 ts +, had a mutation leading to a predicted change in residue 91 of VP3 from phenylalanine in the parent to serine in the mutant as found in Leon. The remaining three, SCC/L2ts +, SCC/L3ts + and SLRlts + all had mutations leading to the same predicted amino acid change in residue 132 of VP 1, which was a phenylalanine in the parent and leucine in the mutant. The base changes in SCCL/2ts + and SCC/L3ts + were different, but gave rise to the same amino acid substitution, and SLRlts + was shown to have the mutation in VP1 characteristic of the parental SLR1. The three mutants were thus independent isolates having the same amino acid change.
Each of the strains isolated from vaccine-associated cases differed from the Sabin vaccine strain at at least one base in the region of the genome coding for the structural proteins. Three (116, 156 and 161) had a back mutation at residue 91 of VP3, sufficient to explain their temperature-resistant phenotype. The remaining strains were presumably rendered non-ts by suppressor mutations. The most common mutation site observed was at residue 54 of VP1. This amino acid was changed from an alanine to a valine in four isolates, and to a threonine in four isolates. A number of substitutions occurred in sites known to be the target of monoclonal antibodies including residue 77 of VP3, residues 164 and 166 of VP2 and residue 286 of VP1 (Minor et al., 1986a) .
DISCUSSION
Of the 10 differences in the genomic sequences of the Leon and the Sabin vaccine strains, the change at residue 2034 is the only one conferring a significant ts phenotype when introduced alone into the genome of Leon. This nucleotide difference leads to the substitution of a serine at amino acid 91 of the capsid protein VP3 of Leon for the phenylalanine found in the Sabin vaccine strain.
However, while non-ts mutants could be readily selected from recombinants which contained the Sabin-like form of VP3, including SV3/L, SCC/L and SLR1, no such mutants could be selected at comparable frequencies from the Sabin vaccine strain, including that recovered from cDNA. This suggests that the VP3 mutation acts with one or more unidentified additional mutations to generate the full ts phenotype of the Sabin type 3 vaccine strain. These additional mutations may have a marginal effect on growth at elevated temperatures when present on their own, and thus be difficult to detect in the cell line used.
The effects of the substitution in VP3 could be suppressed by mutations at other sites. In particular, substitution of a leucine for a phenylalanine at residue 132 of VP1 rendered growth of recombinant viruses completely resistant to 40 °C. This was a very common mutation occurring in three out of four independently selected isolates, and it was therefore surprising that it was not found in any of the isolates from vaccine-associated cases.
As might be expected the isolates from vaccine-associated cases often showed more than one amino acid change. It is likely that the changes found in known antigenic sites do not act as suppressors to the ts phenotype for the following reasons. The constructs SLR1 and SV3/L were Sabin-like at residues 91 of VP3, but Leon-like at residue 286 of VP1, a known antigenic site (Minor et al., 1986a) , and were ts. Mutants of the Sabin vaccine strain have been shown to retain the ts phenotype even when they contain mutations in residues 77 of VP3, 164 of VP2 or 166 of VP2 (data not shown). Finally it has been shown (Minor et al., 1986b) that healthy vaccinees may excrete virus with substitutions at these positions. The variants appear at least 1 week after vaccination, suggesting that they are selected in response to a developing immune pressure rather than elevated temperature in the gut, where selection can be very rapid (Evans et al., 1985) .
The elimination of these changes leaves the 11 substitutions shown in Table 3 as candidates for suppressors of the ts phenotype. It is possible that particular substitutions have a synergistic effect; in particular an alanine to threonine substutition at residue 54 of VP 1 is associated with a back mutation from phenylalanine to serine at residue 91 of VP3 in three out of four isolates, while a substitution of valine for alanine at residue 54 of VP1 is associated with a change from leucine to methionine at residue 215 of VP2 in three out of four isolates. A large proportion of the affected residues including VP2 200, ¥P2 215, VP2 265, VP3 91, VP3 108, VP3 175 and VP3 178 were apparently clustered at the interface between adjacent promoters, as shown in Fig. 1 . In contrast, residue 54 of VP 1 where a substitution was associated with partial suppression of the ts phenotype in isolate 131, was well removed from this interface. Similarly, residue 132 of VP1, where a substitution completely suppressed the ts phenotype in mutants selected in vitro, is located away from the interface and lines the pocket in the beta-barrel of VP1. It is of interest that this pocket is normally filled with an unknown molecule, possibly lipid, in the two poliovirus structures solved to date (Hogle et al., 1985; J. M. Hogle et al., unpublished data) . It is also the site of binding of certain antiviral agents (Smith et al., 1986) . As the agents in question inhibit virus uncoating, it has been postulated that the pocket may be important in this process (Smith et al.. 1986; Ming et al., 1987) . It may also be predicted that interactions between promoters will also be important to uncoating. The ts phenotype of the virus may thus be due to a defect in uncoating or possibly capsid assembly. The precise substitutions responsible for suppression of the ts phenotype in isolates from vaccinees are currently under investigation using site-directed mutagenesis, and their effect on the atomic structure of the virus will be examined.
